GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (CHIX:ORPHAc) » Definitions » Pretax Margin %

Orphazyme AS (CHIX:ORPHAC) Pretax Margin % : % (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Orphazyme AS Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Orphazyme AS's Pre-Tax Income for the three months ended in Jun. 2022 was kr-27.24 Mil. Orphazyme AS's Revenue for the three months ended in Jun. 2022 was kr0.00 Mil. Therefore, Orphazyme AS's pretax margin for the quarter that ended in Jun. 2022 was %.

The historical rank and industry rank for Orphazyme AS's Pretax Margin % or its related term are showing as below:


CHIX:ORPHAc's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.7
* Ranked among companies with meaningful Pretax Margin % only.

Orphazyme AS Pretax Margin % Historical Data

The historical data trend for Orphazyme AS's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orphazyme AS Pretax Margin % Chart

Orphazyme AS Annual Data
Trend Jun14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Pretax Margin %
Get a 7-Day Free Trial - - - - -1,744.76

Orphazyme AS Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -1,586.39 -

Competitive Comparison of Orphazyme AS's Pretax Margin %

For the Biotechnology subindustry, Orphazyme AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orphazyme AS's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's Pretax Margin % falls into.



Orphazyme AS Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Orphazyme AS's Pretax Margin for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-631.48/36.193
=-1,744.76 %

Orphazyme AS's Pretax Margin for the quarter that ended in Jun. 2022 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-27.239/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orphazyme AS  (CHIX:ORPHAc) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Orphazyme AS Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orphazyme AS (CHIX:ORPHAC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200
Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS (CHIX:ORPHAC) Headlines

No Headlines